Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20170112003Phase 1Terminated
Phase 1, randomised, open-label trial of tadalafil (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax and AUC0-72. Started Nov 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20170112003.